The poor sensitivity of 18F-FDG PET/CT in detecting low-grade HCC is probably related to enhanced glucose-6-phosphatase activity causing the dephosphorylation of 18F-FDG-6-PO4, which is therefore not trapped in HCC cells, resulting in false-negative results (29, 30). Here, G6PC1 is linked to hepatocellular carcinoma.